• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chavant Capital Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events

    12/18/23 5:17:07 PM ET
    $CLAY
    Blank Checks
    Finance
    Get the next $CLAY alert in real time by email
    false 0001855467 0001855467 2023-12-18 2023-12-18 0001855467 CLAY:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareAndThreequartersOfOneRedeemableWarrantMember 2023-12-18 2023-12-18 0001855467 us-gaap:CommonStockMember 2023-12-18 2023-12-18 0001855467 CLAY:RedeemableWarrantsEachWarrantExercisableForOneOrdinaryShareEachAtExercisePriceOf11.50PerShareMember 2023-12-18 2023-12-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): December 18, 2023

     

    CHAVANT CAPITAL ACQUISITION CORP.

     

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands 001-40621 98-1591717
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)

     

    445 Park Avenue, 9th Floor

    New York, New York

     

    10022

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (212) 745-1086

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange
    on which registered
    Units, each consisting of one ordinary share, par value $0.0001 per share, and three-quarters of one redeemable warrant   CLAYU   The Nasdaq Stock Market LLC
    Ordinary shares, par value $0.0001 per share   CLAY   The Nasdaq Stock Market LLC
    Redeemable warrants, each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share   CLAYW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨

     

     

     

     

     

    Item 5.07. Submission of Matters to a Vote of Security Holders.

     

    On December 18, 2023, Chavant Capital Acquisition Corp. (the “Company”) held an extraordinary general meeting of shareholders in lieu of an annual general meeting (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, holders of 2,499,412 ordinary shares of the Company, representing approximately 89.94% of all of the shares entitled to vote at the Extraordinary General Meeting, were present in person or were represented by valid proxies; therefore, a quorum was present at the Extraordinary General Meeting.

     

    The shareholders voted on the following proposals at the Extraordinary General Meeting, each of which is described in more detail in the Company’s definitive proxy statement/prospectus filed with the U.S. Securities and Exchange Commission on November 15, 2023 (as supplemented, the “Proxy Statement/Prospectus”). Capitalized terms used but not defined herein have the meanings assigned to such terms in the Proxy Statement/Prospectus.

     

    As there were sufficient votes to approve the Transaction Proposal, the Domestication Proposal, the Organizational Documents Proposal, the Advisory Governance Proposals, the Nasdaq Proposal, the Equity Incentive Plan Proposal, the Employee Stock Purchase Plan Proposal and the Director Election Proposal, the Adjournment Proposal was not presented to shareholders.

     

    Set forth below are the voting results for the Transaction Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    Set forth below are the voting results for the Domestication Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,496,357   3,005   50   N/A

     

    Set forth below are the voting results for the Organizational Documents Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    Set forth below are the voting results for the Advisory Governance Proposals:

     

    (a)  Removal of Special Purpose Acquisition Company Provisions

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    (b) Authorized Capital Stock

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    (c) Voting Rights of Common Stock

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    (d) Right of the Holders of Class B Common Stock to Elect Certain Directors

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    (e) Removal of Directors

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

     

     

     

    (f) Amendment of Charter

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    (g) Amendment of Bylaws

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    (h) Eliminate the Ability of the Holders of Class A Common Stock to Act by Written Consent

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    (i)  Remove Renouncement of Corporate Opportunities

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    (j) Choice of Forum

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    (k) Change of Corporate Name

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    Set forth below are the voting results for the Nasdaq Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,490,390   9,022   0   N/A

     

    Set forth below are the voting results for the Equity Incentive Plan Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,490,389   9,023   0   N/A

     

    Set forth below are the voting results for the Employee Stock Purchase Plan Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,496,408   3,004   0   N/A

     

    Set forth below are the voting results for the Director Election Proposal:

     

    For   Against   Abstain   Broker Non-Votes
    2,496,407   3,005   0   N/A

     

    Item 8.01. Other Events.

     

    In connection with the Extraordinary General Meeting, as of the redemption deadline at 5:00 p.m., Eastern time, on December 14, 2023, shareholders holding 741,613 ordinary shares of the Company exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s trust account established in connection with its initial public offering.  

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      CHAVANT CAPITAL ACQUISITION CORP.
         
    By: /s/ Jiong Ma
      Name: Jiong Ma
      Title: Chief Executive Officer
         
    Date: December 18, 2023    

     

     

     

    Get the next $CLAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLAY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CLAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded

      IRVINE, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, today announced that its previously announced business combination with Chavant Capital Acquisition Corp. ("Chavant") (NASDAQ:CLAY) has closed, resulting in Mobix Labs becoming a publicly traded company. The business combination and all other proposals presented were approved at an extraordinary general meeting of Chavant shareholders held on December 18, 2023. In connection with the completion of the business combination,

      12/21/23 8:59:37 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Effectiveness of Registration Statement on Form S-4

      IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the "SEC") has declared effective the Registration Statement on Form S-4 (as amended, the "Registration Statement") filed by Chavant and relating to the previously announced proposed business combination between Mobix Labs and Chavant (the "Bus

      11/21/23 4:07:00 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Filing of Registration Statement on Form S-4 in Connection With Proposed Business Combination

      IRVINE, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), an innovative provider of next generation wireless mmWave 5G and connectivity solutions, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly-traded special purpose acquisition company, announced today the filing by Chavant with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form S-4 (the "Registration Statement") on April 7, 2023, relating to the previously announced proposed business combination of Chavant and Mobix Labs. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previousl

      4/10/23 8:00:00 AM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Leadership Updates

    Live Leadership Updates

    See more
    • LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

      An international expert in the financing and growth of high tech businesses LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member. "As we enter the clinical stages of a number of drug candidates (HPV, Covid) resulting from our innovative vaccine platform, I am delighted to welcome Dr. Jiong Ma as an addition to our board. With a longstanding focus on the financing and growth of high tech businesses, her role will be to support us in our platform development strategy and to help us achieve our ambitions on a global scale. Dr. Jiong Ma benefits

      5/4/22 6:00:00 AM ET
      $AVXL
      $CLAY
      $SES
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Blank Checks
      Finance

    $CLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chavant Capital Partners Llc disposed of 658,631 shares, bought $1,997,370 worth of shares (199,737 units at $10.00) and acquired 272,182 shares, decreasing direct ownership by 12% to 1,394,101 units (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 6:01:22 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Chavant Capital Acquisition Corp.

      NT 10-Q - MOBIX LABS, INC (0001855467) (Filer)

      2/15/24 4:52:22 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form 424B3 filed by Chavant Capital Acquisition Corp.

      424B3 - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 8:55:31 PM ET
      $CLAY
      Blank Checks
      Finance
    • Chavant Capital Acquisition Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 5:25:19 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chavant Capital Acquisition Corp. (Amendment)

      SC 13G/A - MOBIX LABS, INC (0001855467) (Subject)

      2/9/24 7:26:55 AM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Chavant Capital Acquisition Corp.

      SC 13D - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:21:14 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Chavant Capital Acquisition Corp.

      SC 13G - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:18:58 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Goerner Frederick C was granted 317,244 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:51:34 PM ET
      $CLAY
      Blank Checks
      Finance
    • Peterson James J was granted 2,404,845 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:50:44 PM ET
      $CLAY
      Blank Checks
      Finance
    • Carpou Bill was granted 73,752 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:48:00 PM ET
      $CLAY
      Blank Checks
      Finance